Abivax S.A.
ABVX
87.01
-1.21
-1.37%
Abivax S.A.
US · ABVX
#1658 by market cap
Listed 2023
87.01
-1.21
-1.37%
Live - 5344 symbols - heartbeat 143s ago
· 2026-10-08 07:37
Pre-market
86.05
-1.10%
After-hours
87.43
+0.48%
Overnight
86.04
-1.11%
- Market cap
- 7.59B
- P/E (TTM)i
- -14.58
- P/Bi
- 18.52
- EPSi
- -5.41
- Div yieldi
- 0.00%
- 52W posi
- 22%
Reader sentiment
Are you bullish or bearish on ABVX?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 8 analysts
Buy
Avg price target
158.75 +82.5%
Price target rangecurrent 87.01
Low118.00
Avg158.75
High180.00
Buy 88%
Hold 13%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-10-01 | BTIG | -- | BUY | 175.00 |
| 2026-09-28 | BTIG | -- | BUY | 175.00 |
| 2026-09-28 | Morgan Stanley | -- | BUY | 180.00 |
| 2026-09-22 | LifeSci Capital | -- | BUY | 168.00 |
| 2026-09-22 | BTIG | -- | BUY | 175.00 |
| 2026-09-22 | Truist Financial | -- | BUY | 151.00 |
| 2026-09-22 | Wedbush | -- | HOLD | 118.00 |
| 2026-09-22 | Morgan Stanley | -- | BUY | 180.00 |
| 2026-09-22 | Barclays | -- | BUY | 148.00 |
| 2026-09-09 | Goldman Sachs | -- | BUY | 155.00 |
| 2026-07-24 | Morgan Stanley | -- | BUY | 180.00 |
| 2026-07-09 | Piper Sandler | -- | BUY | 175.00 |
| 2026-07-02 | Truist Financial | -- | BUY | 155.00 |
| 2026-07-01 | Jefferies | -- | BUY | 158.00 |
| 2026-07-01 | Guggenheim | -- | BUY | 175.00 |
| 2026-06-30 | LifeSci Capital | -- | BUY | 170.00 |
| 2026-06-30 | Piper Sandler | -- | BUY | 165.00 |
| 2026-06-30 | BTIG | -- | BUY | 175.00 |
| 2026-06-30 | Truist Financial | -- | BUY | -- |
| 2026-06-30 | Wedbush | -- | HOLD | 110.00 |
| 2026-06-30 | Jefferies | -- | BUY | 158.00 |
| 2026-06-30 | Barclays | -- | BUY | 148.00 |
| 2026-06-22 | Truist Financial | -- | BUY | 135.00 |
| 2026-06-16 | LifeSci Capital | -- | BUY | 170.00 |
| 2026-06-16 | Piper Sandler | -- | BUY | 165.00 |
Quant vs Street three independent views, side by side
Momentum strategy signal
Sell
Analyst consensus
Buy
Signals diverge - worth digging into why.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
✦ Quant Analyst Revision Trend how this is computed
Mixed
1
■ Upgrades■ Downgrades
- 1 upgrade vs 0 downgrades among tracked analyst rating changes.
- Most recent: Wedbush moved from Sell to Hold on 2026-06-30.
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-06-30 | Wedbush | SELL → HOLD | 110.00 |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q2 | 2026-09-21 | -- | ±8.08% | -4.99% (in line) |
| 2026/Q1 | 2026-05-22 | -- | ±15.39% | +3.62% (in line) |
| 2025/Q4 | 2026-03-23 | -- | ±9.63% | -4.55% (in line) |
| 2025/Q3 | 2025-12-15 | After close | ±12.42% | -5.88% (in line) |
| 2025/Q2 | 2025-09-08 | -- | -- | -0.83% |
| 2025/Q1 | 2025-06-02 | After close | -- | +21.89% |
| 2024/Q4 | 2025-03-24 | After close | -- | -0.41% |
| 2024/Q3 | 2024-11-07 | -- | -- | +1.35% |
| 2024/Q2 | 2024-09-09 | -- | -- | -2.83% |
| 2023/Q4 | 2024-04-02 | -- | -- | +0.50% |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-10-08 07:37:10 · For reference only, not investment advice and not tailored to your situation.